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\[Correction added on 18 June 2020, after first online publication: "Lukes" was updated to "Luke\'s" in the affiliation\]

In coronavirus disease 2019 (COVID‐19) patients treated with veno‐venous extracorporeal membrane oxygenation (VV‐ECMO) generally need anticoagulant therapy.

A 56‐year‐old man with a history of diabetes was admitted to ICU for severe COVID‐19 pneumonia. He was intubated on day 3 and VV‐ECMO was established on day 5 because of severe hypoxia. We administered unfractionated heparin with carefully monitored activated partial thromboplastin time ranging from 40 to 60 seconds; however, he had rectal bleeding requiring endoscopic clipping and artificial lung thrombosis during VV‐ECMO management. His minimum platelet count and maximum D‐dimer in this period were 3.6 × 109/mL and 18.4 µg/mL, respectively. He was weaned from VV‐ECMO after 7 days but remained comatose. On day 15 brain computed tomography (CT) showed multiple subcortical hemorrhage (Figure [1A](#emp212154-fig-0001){ref-type="fig"}). He awoke slowly and was able to communicate, walk, and be discharged from ICU. Follow‐up cerebral MRI on day 57 revealed diffuse microbleeds in subcortical and deep white matter on T2\*‐weighted images (Figure [1B](#emp212154-fig-0001){ref-type="fig"}) and susceptibility‐weighted imaging (SWI) (Figure [1C](#emp212154-fig-0001){ref-type="fig"}). He also had minor lacuna in frontal deep matter on T2‐FLAIR (Figure [1D](#emp212154-fig-0001){ref-type="fig"}) and minor cognitive impairment. Cerebral MRI is more useful than CT for detecting microbleeds.
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